Publications by authors named "Heather A Wakelee"

100Publications

A PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORS.

Cancer Treat Res Commun 2020 Apr 20;23:100174. Epub 2020 Apr 20.

Stanford University School of Medicine, Department of Internal Medicine, Division of Oncology, Stanford Cancer Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100174DOI Listing
April 2020

Adjuvant Chemotherapy.

Thorac Surg Clin 2020 May 2;30(2):179-185. Epub 2020 Mar 2.

Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thorsurg.2020.01.003DOI Listing
May 2020

Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes".

Lung Cancer 2019 11 26;137:159-160. Epub 2019 Aug 26.

Stanford Cancer Institute, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.08.020DOI Listing
November 2019

Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer.

Lung Cancer 2019 08 3;134:42-45. Epub 2019 May 3.

Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.002DOI Listing
August 2019

Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes.

Lung Cancer 2019 07 15;133:144-150. Epub 2019 May 15.

Stanford Cancer Institute, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94304, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.015DOI Listing
July 2019

Role of Immunotherapy in Small Cell Lung Cancer, Thymic Epithelial Tumors, and Mesothelioma.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:543-552. Epub 2019 May 17.

4 Division of Oncology, Department of Medicine, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_237847DOI Listing
January 2019

Tumor Heterogeneity and Testing Discrepancy Confound ROS1 Detection in NSCLC.

J Thorac Oncol 2019 06 23;14(6):e111-e113. Epub 2019 Mar 23.

Department of Medical Oncology, Stanford Cancer Institute, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.03.011DOI Listing
June 2019

Increased Galectin-1 Expression in Thymic Epithelial Tumors.

Clin Lung Cancer 2019 05 21;20(3):e356-e361. Epub 2018 Dec 21.

Department of Radiation Oncology, Stanford University School of Medicine Stanford Cancer Institute, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.12.005DOI Listing
May 2019

Case closed: another prophylactic cranial irradiation trial for stage 3 non-small cell lung cancer fails to improve overall survival.

Ann Transl Med 2018 Dec;6(Suppl 2):S118

Department of Neurology, Stanford University School of Medicine, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.12.24DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330621PMC
December 2018

Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and Vietnam.

J Glob Oncol 2018 11;4:1-9

Kim-Son H. Nguyen, Palo Alto Medical Foundation, Mountain View; Henning Stehr, Li Zhou, Heather A. Wakelee, Maximilian Diehn, and Joel W. Neal, Stanford University School of Medicine, Stanford; Anh-Hoa Nguyen, AK Research Group, Redwood City, CA; Pham Nhu Hiep, Nguyen Van Cau, Hue Central Hospital; Phan Canh Duy, Hue University School of Medicine and Pharmacy, Hue, Vietnam; and Richard Thorp, BioreclamationIVT, Chestertown, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.18.00086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818292PMC
November 2018

Lengthy Progression-Free Survival and Intracranial Activity of Cabozantinib in Patients with Crizotinib and Ceritinib-Resistant ROS1-Positive Non-Small Cell Lung Cancer.

J Thorac Oncol 2019 02 11;14(2):e21-e24. Epub 2018 Sep 11.

Department of Medical Oncology, Stanford Cancer Institute, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.08.2030DOI Listing
February 2019

Caution Needed for Analyzing the Risks of Second Cancers.

J Thorac Oncol 2018 09;13(9):e172-e173

Department of Medicine, Stanford University School of Medicine, Stanford, California; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.018DOI Listing
September 2018

Osimertinib for -Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study.

Oncologist 2019 06 20;24(6):836-843. Epub 2018 Aug 20.

Division of Oncology, Stanford University School of Medicine, Stanford, California, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656518PMC
June 2019

Perspectives on Acquired Resistance to PD-1 Axis Inhibitors in Patients with Non-Small Cell Lung Cancer.

J Thorac Oncol 2018 06;13(6):741-744

Stanford Cancer Institute, Stanford University, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183053
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.04.008DOI Listing
June 2018

Circulating tumor DNA testing in advanced non-small cell lung cancer.

Lung Cancer 2018 05 2;119:42-47. Epub 2018 Mar 2.

Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.02.019DOI Listing
May 2018

Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS.

Curr Treat Options Oncol 2017 11 16;18(12):71. Epub 2017 Nov 16.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, CC-2233, 875 Blake Wilbur Drive, Palo Alto, CA, 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-017-0513-xDOI Listing
November 2017

The J-ALEX trial-is frontline alectinib a new standard of care?

J Thorac Dis 2017 Aug;9(8):2242-2245

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.06.134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594119PMC
August 2017

Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer.

Radiother Oncol 2017 11 19;125(2):338-343. Epub 2017 Aug 19.

Department of Radiation Oncology, Stanford University, USA; Stanford Cancer Institute, Stanford University School of Medicine, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2017.08.007DOI Listing
November 2017

Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.

Int J Radiat Oncol Biol Phys 2017 09 6;99(1):16-21. Epub 2017 May 6.

Department of Radiation Oncology, Stanford University, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.04.041DOI Listing
September 2017

Risk Stratification for Second Primary Lung Cancer.

J Clin Oncol 2017 Sep 23;35(25):2893-2899. Epub 2017 Jun 23.

Summer S. Han, Sylvia K. Plevritis, and Heather A. Wakelee, Stanford University School of Medicine; Summer S. Han, Sylvia K. Plevritis, Scarlett L. Gomez, Iona Cheng, and Heather A. Wakelee, Stanford Cancer Institute; Heather A. Wakelee and Gabriel A. Rivera, Stanford University Department of Medicine, Division of Oncology, Stanford; Gabriel A. Rivera, Kaiser Permanente Fresno Medical Center, Fresno; Scarlett L. Gomez and Iona Cheng, Cancer Prevention Institute of California, Fremont, CA; and Martin C. Tammemägi, Brock University, St Catharines, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.4203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946715PMC
September 2017

A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer.

Lung Cancer 2017 06 29;108:173-182. Epub 2017 Mar 29.

Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr, MC 5847, Stanford, CA 94305, United States; Stanford Cancer Institute, 265 Campus Drive, Ste G2103, Stanford, CA 94305, United States; Institute for Stem Cell Biology and Regenerative Medicine, 265 Campus Drive, 3rd Floor Stanford, CA 94305, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.03.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502824PMC
June 2017

Targeting -Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.

Oncologist 2017 07 9;22(7):786-796. Epub 2017 May 9.

Stanford University Medical Center, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507646PMC
July 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

ERBB2-Mutated Metastatic Non-Small Cell Lung Cancer: Response and Resistance to Targeted Therapies.

J Thorac Oncol 2017 05 4;12(5):833-842. Epub 2017 Feb 4.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.01.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402884PMC
May 2017

Elusive Target of Angiogenesis in Small-Cell Lung Cancer.

J Clin Oncol 2017 04 6;35(12):1269-1271. Epub 2017 Feb 6.

Joel W. Neal and Heather A. Wakelee, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.6084DOI Listing
April 2017

Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung Cancer.

Hematol Oncol Clin North Am 2017 02;31(1):31-44

Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, 875 Blake Wilbur Drive, Room 2233, Stanford, CA 94305-5826, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2016.08.011DOI Listing
February 2017

Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?

Curr Atheroscler Rep 2016 Dec;18(12):72

Department of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11883-016-0625-yDOI Listing
December 2016

Pretreatment biopsy for thymic epithelial tumors-does histology subtype matter for treatment strategy?

J Thorac Dis 2016 Aug;8(8):1895-900

Department of Medicine (Oncology), Stanford University/Stanford Cancer Institute, Stanford, CA, USA ;

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/8340/7841
Publisher Site
http://dx.doi.org/10.21037/jtd.2016.06.77DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999713PMC
August 2016

Resistance to Therapy.

Cancer Treat Res 2016;170:183-202

Stanford University, Stanford Cancer Institute, 875 Blake Wilbur Drive, Stanford, CA, 94305-5826, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-40389-2_9DOI Listing
June 2017

Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.

Clin Lung Cancer 2017 01 27;18(1):5-12. Epub 2016 Jun 27.

Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.06.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361177PMC
January 2017

Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.

Clin Ther 2016 Jul 29;38(7):1567-76. Epub 2016 Jun 29.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2016.06.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985173PMC
July 2016

Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directions.

Expert Opin Pharmacother 2016 4;17(7):989-93. Epub 2016 Apr 4.

b Department of Medicine, Division of Oncology , Stanford University School of Medicine , Stanford , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2016.1162786DOI Listing
September 2016

Lung Cancer Survival Among Chinese Americans, 2000 to 2010.

J Glob Oncol 2016 Feb 20;2(1):30-38. Epub 2016 Jan 20.

, , , and , Cancer Prevention Institute of California, Fremont; and , Stanford School of Medicine; , , , , and , Stanford Cancer Institute, Stanford; and , , and , Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2015.000539DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497738PMC
February 2016

Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.

Clin Lung Cancer 2016 Mar 18;17(2):e17-21. Epub 2015 Dec 18.

Division of Medical Oncology, Stanford Hospital and Clinics, Stanford, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2015.12.001DOI Listing
March 2016

Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy.

J Cutan Pathol 2016 Apr 10;43(4):339-46. Epub 2016 Feb 10.

Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12666DOI Listing
April 2016

Racial and Ethnic Variations in Lung Cancer Incidence and Mortality: Results From the Women's Health Initiative.

J Clin Oncol 2016 Feb 23;34(4):360-8. Epub 2015 Dec 23.

Manali I. Patel, Ange Wang, Kristopher Kapphahn, Manisha Desai, Marcia L. Stefanick, and Heather A. Wakelee, Stanford University School of Medicine; Marcia L. Stefanick, Stanford Prevention Research Center; Heather A. Wakelee, Stanford Cancer Institute, Stanford; Rowan T. Chlebowski, Harbor-University of California, Los Angeles, Medical Center, Torrance; Chloe E. Bird, RAND Corporation, Santa Monica; Scarlett Lin Gomez, Cancer Prevention Institute of California, Fremont, CA; Michael S. Simon and Michele L. Cote, Karmanos Cancer Institute Detroit, MI; Giselle Corbie-Smith, University of North Carolina, Chapel Hill, NC; and Lucile L. Adams-Campbell, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.5789DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872034PMC
February 2016

Pruritus as a Paraneoplastic Symptom of Thymoma.

J Thorac Oncol 2015 Nov;10(11):e110-2

*Division of Oncology, Department of Medicine, †Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California; ‡Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, California; §Stanford Thoracic Oncology, Stanford Health Care, Stanford, California; ¶Department of Dermatology, Stanford University School of Medicine, Stanford, California; ‖Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China; #Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; **Department of Pathology, ††Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; ‡‡Division of Oncology, Department of Medicine, Ukiah Valley Rural Health Center, Ukiah, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000623DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720251PMC
November 2015

Adjuvant therapy for EGFR mutant and ALK positive NSCLC: Current data and future prospects.

Lung Cancer 2015 Oct 30;90(1):1-7. Epub 2015 Jul 30.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.07.016DOI Listing
October 2015

Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.

Am J Ophthalmol 2015 Oct 17;160(4):799-805.e1. Epub 2015 Jul 17.

Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajo.2015.07.012DOI Listing
October 2015

Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interaction.

Lung Cancer 2015 Sep 22;89(3):280-6. Epub 2015 Jun 22.

Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613811PMC
September 2015

Incidence trends of lung cancer by immigration status among Chinese Americans.

Cancer Epidemiol Biomarkers Prev 2015 Aug 19;24(8):1157-64. Epub 2015 May 19.

Cancer Prevention Institute of California, Fremont, California. Department of Health Research and Policy (Epidemiology), Stanford School of Medicine, Stanford, California. Stanford Cancer Institute, Palo Alto, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746176PMC
August 2015

Rociletinib in EGFR-mutated non-small-cell lung cancer.

N Engl J Med 2015 Apr;372(18):1700-9

From Massachusetts General Hospital (L.V.S., R.S.H., J.L., Z.P.), Harvard Medical School (L.V.S., G.R.O., R.S.H., Z.P.), and Dana-Farber Cancer Institute (G.R.O.) - all in Boston; the Drug Development Department, Université Paris-Sud, Gustave Roussy Cancer Campus (J.-C.S.), and Institut Gustave Roussy (A.V.), Villejuif - both in France; the David Geffen School of Medicine, University of California, Los Angeles, Los Angeles (J.W.G., E.B.G., M.A.M., S.N.), and Stanford Cancer Institute, Stanford University, Stanford (H.A.W., J.W.N.) - both in California; the Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit (S.M.G., C.G., A.J.W.); University of Texas M.D. Anderson Cancer Center, Houston (V.P.); the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.J.S.); the Medical University of Gdansk, Gdansk, Poland (R.D.); the University of Colorado (D.L.A., D.R.C.) and University of Colorado Cancer Center (R.C.D.) - both in Aurora; and Clovis Oncology, San Francisco (M.R., C.A.K., S.J.-T., S.L.M., A.R.A.), Boulder, CO (J.I., D.D.), and Cambridge, United Kingdom (L.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1413654DOI Listing
April 2015

GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray.

Anticancer Res 2015 Feb;35(2):669-76

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, U.S.A.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973531PMC
February 2015

Relationship of Driver Oncogenes to Long-Term Pemetrexed Response in Non--Small-Cell Lung Cancer.

Clin Lung Cancer 2015 Sep 31;16(5):366-73. Epub 2014 Dec 31.

Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.12.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490141PMC
September 2015

Pemetrexed in patients with thymic malignancies previously treated with chemotherapy.

Lung Cancer 2015 Jan 15;87(1):34-8. Epub 2014 Nov 15.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.11.006DOI Listing
January 2015

Diffuse high intensity PD-L1 staining in thymic epithelial tumors.

J Thorac Oncol 2015 Mar;10(3):500-8

*Division of Oncology, Department of Internal Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA; †Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA; ‡Department of Pathology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA; and §Department of Health and Research Policy, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000429DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720257PMC
March 2015

Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010.

Cancer Epidemiol Biomarkers Prev 2014 Nov;23(11):2250-65

Cancer Prevention Institute of California, Fremont, California. Stanford Cancer Institute, Stanford, California. Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-0493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738466PMC
November 2014

Are Patients With Thoracic Malignancies at Risk for Uncontrolled Symptoms?

J Oncol Pract 2015 01 30;11(1):e98-e102. Epub 2014 Sep 30.

Stanford University; Stanford Hospitals and Clinics, Stanford; and University of California Los Angeles, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2014.001502DOI Listing
January 2015

Commentary: highlights in NSCLC from the 15th World Conference on Lung Cancer.

Clin Adv Hematol Oncol 2014 Jan;12(1 Suppl 1):17-21

Stanford University Medical Center, Stanford, California.

View Article

Download full-text PDF

Source
January 2014

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

Nat Med 2014 May 6;20(5):548-54. Epub 2014 Apr 6.

1] Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California, USA. [2] Department of Radiation Oncology, Stanford University, Stanford, California, USA. [3] Stanford Cancer Institute, Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nm.3519
Publisher Site
http://dx.doi.org/10.1038/nm.3519DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016134PMC
May 2014

Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy.

Semin Oncol 2014 Feb 12;41(1):40-56. Epub 2013 Dec 12.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.12.011DOI Listing
February 2014

Commentary: highlights in NSCLC from the 15th World Conference on Lung Cancer.

Clin Adv Hematol Oncol 2014 Jan;12 Suppl 3(1):17-21

Stanford University Medical Center, Stanford, CA.

View Article

Download full-text PDF

Source
January 2014

Response.

Chest 2013 Dec;144(6):1971-1972

Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA; Veterans Affairs Palo Alto Healthcare System, Stanford, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.13-1931DOI Listing
December 2013

Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC).

Transl Lung Cancer Res 2013 Oct;2(5):403-10

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2013.07.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367729PMC
October 2013

How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox.

J Clin Oncol 2013 Oct 19;31(28):3572-8. Epub 2013 Aug 19.

Manali I. Patel, Scarlett L. Gomez, Ellen T. Chang, and Heather A. Wakelee, Stanford University; Scarlett L. Gomez and Heather A. Wakelee, Stanford Cancer Institute, Stanford; Clayton W. Schupp and Scarlett L. Gomez, Cancer Prevention Institute of California, Fremont; and Ellen T. Chang, Exponent Health Sciences Practices, Menlo Park, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.6217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782149PMC
October 2013

miR-1 induces growth arrest and apoptosis in malignant mesothelioma.

Chest 2013 Nov;144(5):1632-1643

Division of Thoracic Surgery, Department of Medicine, Stanford University School of Medicine, Stanford, CA; Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.12-2770DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694093PMC
November 2013